Literature DB >> 30831080

LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.

Qianru Dou1, Yang Xu1, Yuanyuan Zhu1, Yakun Hu1, Yuchen Yan2, Hongchao Yan3.   

Abstract

Ovarian cancer (OC) is a major cause of cancer-related deaths in women all over the world. The easy metastasis of OC and the problem of radioresistance are serious issues remaining to be overcome. Thus, research on molecular mechanisms underlying is in urgent demand. Long non-coding RNAs (lncRNAs) are a class of RNAs without protein coding potential, which has been reported to participate in the regulation on multiple biological process in cancers, including cell radiosensitivity and metastasis. Present study aimed to explore the role of lncRNA FAM83-AS1 in radioresistance and metastasis of ovarian cancer. First of all, the obvious upregulation of FAM83H-AS1 was identified by qRT-PCR in OC tissues, especially in metastatic tissues, as well as in OC cell lines. Importantly, we confirmed the correlation of FAM83H-AS1 levels with both ovarian cancer cells and normal ovarian cells. And Kaplan-Meier analysis indicated FAM83H-AS1 as a potential target of poor prognosis of OC. Through loss-of-function assays, we validated the inductive effect of FAM83H-AS1 in OC cell metastasis and radioresistance. Through mechanism research on FAM83H-AS1, we confirmed its interaction with HuR using pull-down assay and RNA immunoprecipitation (RIP), and verified the stabilization of HuR protein by FAM83-AS1 through western blot with the addition of CHX. Finally, rescue assays showed that overexpression of HuR rescued the suppression on radioresistance and metastasis in OC cell caused by the silencing of FAM83H-AS1. In conclusion, present study proved that FAM83H-AS1 contributes to the radioresistance and cell metastasis in ovarian cancer through stabilizing HuR protein.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FAM83H-AS1; HuR; Metastasis; Ovarian cancer; Radioresistance

Mesh:

Substances:

Year:  2019        PMID: 30831080     DOI: 10.1016/j.ejphar.2019.03.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

1.  LncRNA MIAT Promotes Spinal Cord Injury Recovery in Rats by Regulating RBFOX2-Mediated Alternative Splicing of MCL-1.

Authors:  Xin He; Jianan Zhang; Yunshan Guo; Xiaowei Yang; Yunfei Huang; Dingjun Hao
Journal:  Mol Neurobiol       Date:  2022-05-31       Impact factor: 5.682

2.  HuR Affects the Radiosensitivity of Esophageal Cancer by Regulating the EMT-Related Protein Snail.

Authors:  Yan Hu; Qing Li; Ke Yi; Chi Yang; Qingjun Lei; Guanghui Wang; Qianyun Wang; Xiaohui Xu
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

3.  Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells.

Authors:  Wenguang Luo; Wei Liu; Jie Yao; Wenjing Zhu; Hongyan Zhang; Qi Sheng; Lin Wang; Lei Lv; Liting Qian
Journal:  Onco Targets Ther       Date:  2019-06-19       Impact factor: 4.147

Review 4.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

5.  LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703.

Authors:  Xin Wang; Xinghua Gan; Chengcheng Liu; Wenfeng Zhang
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

6.  LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.

Authors:  Chunyong Han; Yiwei Fu; Ni Zeng; Jian Yin; Qian Li
Journal:  Aging (Albany NY)       Date:  2020-02-17       Impact factor: 5.682

Review 7.  The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis.

Authors:  Qin Yang; Jie Wang; Pingyong Zhong; Tinggang Mou; Hao Hua; Pan Liu; Fei Xie
Journal:  Cancer Cell Int       Date:  2020-03-06       Impact factor: 5.722

8.  Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.

Authors:  Xiaolei Yuan; Ying Huang; Man Guo; Xiaowei Hu; Peiling Li
Journal:  J Ovarian Res       Date:  2021-01-07       Impact factor: 4.234

9.  Downregulation of lncRNA XIST Represses Tumor Growth and Boosts Radiosensitivity of Neuroblastoma via Modulation of the miR-375/L1CAM Axis.

Authors:  Haiyan Yang; Xiao Zhang; Yuehua Zhao; GuoLi Sun; Jian Zhang; Yiwen Gao; Qian Liu; Wenhua Zhang; Hongjin Zhu
Journal:  Neurochem Res       Date:  2020-08-28       Impact factor: 3.996

10.  FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients.

Authors:  Magdalena Ríos-Romero; Alberto Cedro-Tanda; Mónica Peña-Luna; Marco Antonio Mancera-Rodríguez; Lizbett Hidalgo-Pérez; Mireya Cisneros-Villanueva; Fredy Omar Beltrán-Anaya; Rocío Arellano-Llamas; Silvia Jiménez-Morales; Luis Alberto Alfaro-Ruíz; Alberto Tenorio-Torres; Carlos Domínguez-Reyes; Felipe Villegas-Carlos; Elsa Ochoa-Mendoza; Alfredo Hidalgo-Miranda
Journal:  Sci Rep       Date:  2020-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.